MarketCap
Facebook
X
Telegram
Apellis Pharmaceuticals EV - Enterprise Value | APLS
Annual EV - Enterprise Value Apellis Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.01 B | 3.33 B | 8.52 B | 6.49 B | 3.44 B | 3.52 B | 2.59 B | 604 M | 111 M | -21.2 M | 3.2 M | 1.08 M | 677 K | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.52 B | -21.2 M | 2.43 B |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M |  USA |
 |
Applied Therapeutics
APLT
|
-49.7 M | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-26.7 M | - | - | $ 8.86 M |  Canada |
 |
Generation Bio Co.
GBIO
|
68.7 M | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
44 M | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
2.82 B | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
-72 M | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
673 M | $ 4.0 | -7.62 % | $ 620 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
43.3 B | $ 156.5 | -2.85 % | $ 20.5 B | USA |
 |
Amgen
AMGN
|
189 B | $ 462.71 | -3.3 % | $ 249 B | USA |
 |
Theratechnologies
THTX
|
139 M | - | - | $ 83.9 M | Canada |
 |
Iovance Biotherapeutics
IOVA
|
52.9 M | $ 7.72 | -11.26 % | $ 2.76 M | USA |
 |
Biogen
BIIB
|
37.6 B | $ 243.85 | -4.17 % | $ 35.7 B | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
-115 M | $ 4.03 | 6.9 % | $ 652 M | USA |
 |
Armata Pharmaceuticals
ARMP
|
599 M | $ 3.01 | -4.14 % | $ 109 M | USA |
 |
Mustang Bio
MBIO
|
-5.03 M | $ 0.39 | -5.63 % | $ 1.91 M | USA |
 |
MannKind Corporation
MNKD
|
1.76 B | $ 3.77 | -4.07 % | $ 1.15 B | USA |
 |
InflaRx N.V.
IFRX
|
60.9 M | $ 1.36 | -8.11 % | $ 91.5 M |  Germany |
 |
Immutep Limited
IMMP
|
2.92 B | $ 2.7 | -8.47 % | $ 3.93 B |  Australia |
 |
Insmed Incorporated
INSM
|
32.6 B | $ 108.79 | -1.1 % | $ 21.7 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
-2.35 M | - | -3.76 % | $ 3.47 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
9.15 B | $ 227.25 | -3.16 % | $ 13.9 B |  Irlanda |
 |
BioLineRx Ltd.
BLRX
|
5.66 B | $ 1.77 | -4.95 % | $ 4.36 B |  Israel |
 |
Bristol-Myers Squibb Company
BMY
|
184 B | $ 63.15 | -1.64 % | $ 128 B | USA |
 |
Johnson & Johnson
JNJ
|
98 B | $ 272.47 | -1.4 % | $ 656 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
11.9 M | - | 3.16 % | $ 1.9 M | USA |
 |
PainReform Ltd.
PRFX
|
1.3 M | $ 0.76 | -1.27 % | $ 492 K | Israel |
 |
Kala Pharmaceuticals
KALA
|
-3.43 M | $ 0.15 | -13.14 % | $ 1.22 M | USA |
 |
Prothena Corporation plc
PRTA
|
-10.4 M | $ 7.9 | -5.84 % | $ 425 M | USA |
 |
TCR2 Therapeutics
TCRR
|
92.6 M | - | - | $ 58.1 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
153 B | $ 14.53 | -1.63 % | $ 12.1 B |  India |
 |
Keros Therapeutics
KROS
|
261 M | $ 9.42 | -13.02 % | $ 351 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
4.14 B | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Kazia Therapeutics Limited
KZIA
|
10 M | $ 7.13 | -11.76 % | $ 109 M | Australia |
 |
TFF Pharmaceuticals
TFFP
|
7.83 M | - | -60.05 % | $ 125 K | USA |
 |
Sana Biotechnology
SANA
|
1.18 B | $ 2.32 | -9.38 % | $ 588 M | USA |
 |
Lineage Cell Therapeutics
LCTX
|
450 M | $ 0.98 | -4.85 % | $ 226 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
2.33 B | $ 298.8 | -5.48 % | $ 5.78 B | USA |
 |
Longeveron
LGVN
|
16.9 B | $ 1.76 | -1.12 % | $ 30.9 B | USA |
 |
Eli Lilly and Company
LLY
|
933 B | $ 1 366.97 | -3.62 % | $ 1.23 T | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
143 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
111 M | - | - | $ 521 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
3.75 M | $ 4.01 | -5.2 % | $ 48.9 M | Israel |
 |
Axcella Health
AXLA
|
22.6 M | - | -16.42 % | $ 249 M | USA |
 |
Compugen Ltd.
CGEN
|
106 M | $ 1.94 | -4.68 % | $ 181 M | Israel |
 |
Liquidia Corporation
LQDA
|
3.04 B | $ 44.46 | -6.16 % | $ 3.83 B | USA |
 |
Sarepta Therapeutics
SRPT
|
3.05 B | $ 17.5 | -7.77 % | $ 1.75 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.02 B | - | - | $ 2.02 B | USA |
 |
Shattuck Labs
STTK
|
304 M | $ 4.46 | -11.84 % | $ 310 M | USA |
 |
Mesoblast Limited
MESO
|
12.6 B | $ 14.08 | -1.47 % | $ 17 B | Australia |